JAK2 wild-type erythrocytosis associated with sodium-glucose cotransporter 2 inhibitor therapy

被引：19
|
作者：
Gangat, Naseema [1 ]
Szuber, Natasha [2 ]
Alkhateeb, Hassan [1 ]
Al-Kali, Aref [1 ]
Pardanani, Animesh [1 ]
Tefferi, Ayalew [1 ]
机构：
[1] Mayo Clin, Dept Internal Med, Div Hematol, Rochester, MN 85259 USA
[2] Univ Montreal, Dept Hematol, Montreal, PQ, Canada
来源：
BLOOD | 2021年 / 138卷 / 26期
关键词：
MECHANISM;
D O I：
10.1182/blood.2021013996
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2886 / 2889
页数：4
相关论文
共 50 条
  • [31] Renal threshold for glucose reabsorption predicts diabetes improvement by sodium-glucose cotransporter 2 inhibitor therapy
    Osaki, Aya
    Okada, Shuichi
    Saito, Tsugumichi
    Yamada, Eijiro
    Ono, Kumeo
    Niijima, Yawara
    Hoshi, Hiroto
    Yamada, Masanobu
    JOURNAL OF DIABETES INVESTIGATION, 2016, 7 (05): : 751 - 754
  • [32] The Renal Threshold for Glucose Reabsorption Predicts Diabetes Improvement by Sodium-Glucose Cotransporter 2 Inhibitor Therapy
    Okada, Shuichi
    Yamada, Masanobu
    DIABETES, 2017, 66 : A323 - A323
  • [33] Sodium-glucose Cotransporter 2 Inhibitor-induced Diabetic Ketoacidosis in a Type 2 Diabetic Patient
    Tello, Edna M. Juarez Ramirez
    Orellana-Barrios, Menfil A.
    Nugent, Kenneth
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2016, 351 (06): : 634 - 635
  • [34] Postoperative Euglycemic Ketoacidosis in Type 2 Diabetes Associated with Sodium-Glucose Cotransporter 2 Inhibitor: Insights Into Pathogenesis and Management Strategy
    Chandrakumar, Harshith P.
    Chillumuntala, Seeta
    Singh, Gurcharan
    McFarlane, Samy I.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)
  • [35] Sodium-glucose cotransporter type 2 inhibitors and cardiac arrhythmias
    Manolis, Antonis A.
    Manolis, Theodora A.
    Melita, Helen
    Manolis, Antonis S.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2023, 33 (07) : 418 - 428
  • [36] Tubulointerstitial Nephritis after Using a Sodium-glucose Cotransporter 2 Inhibitor
    Konta, Yusuke
    Saito, Eiichiro
    Sato, Koji
    Furuta, Kyohei
    Miyauchi, Kenichiro
    Furukawa, Akiko
    Sato, Hiroshi
    Yamamoto, Tae
    INTERNAL MEDICINE, 2022, 61 (21) : 3239 - 3243
  • [37] Ipragliflozin: A novel sodium-glucose cotransporter 2 inhibitor developed in Japan
    Ohkura, Tsuyoshi
    WORLD JOURNAL OF DIABETES, 2015, 6 (01) : 136 - 144
  • [38] Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy
    Arow, M.
    Waldman, M.
    Yadin, D.
    Nudelman, V.
    Shainberg, A.
    Abraham, N. G.
    Freimark, D.
    Kornowski, R.
    Aravot, D.
    Hochhauser, E.
    Arad, M.
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [39] Canagliflozin, a new sodium-glucose cotransporter 2 inhibitor, in the treatment of diabetes
    Nisly, Sarah A.
    Kolanczyk, Denise M.
    Walton, Alison M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (04) : 311 - 319
  • [40] Diabetic Ketoacidosis With Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, in Patients With Type 1 Diabetes
    Peters, Anne L.
    Henry, Robert R.
    Thakkar, Payal
    Tong, Cindy
    Alba, Maria
    DIABETES CARE, 2016, 39 (04) : 532 - 538
12345